Ombitasvir + paritaprevir + ritonavir (Viekirax)

BNF:
not listed
Status:
Red
Decision Date:
March 2015
 

Comments

RED1,2,3: NICE TA365: treating chronic hepatitis C (Decision date - December 2015).

NHS England drug - to be used in line with NHS England commissioning intentions

 

 

Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
  • 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again